Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT03919305

Cerebral Venous Thrombosis Cohort Study in China Mainland

Status
Not Yet Recruiting
Phase
Study type
Observational
Enrollment
3,000 (estimated)
Sponsor
Capital Medical University · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

This study was aimed to reveal the clinical features,natural history of the diseases and current therapeutic situations of cerebral venous thrombosis (CVT) in China mainland. Blood samples and cerebrospinal fluid samples will be collected after recruitment to reveal the pathological mechanisms of CVT and identify the biomarkers for CVT.

Detailed description

cerebral venous thrombosis (CVT) is caused by a clot in the cerebral vein, which resulted in an obstruction of the blood outflow. CVT mainly includes cerebral venous sinus thrombosis, deep cerebral vein thrombosis and cortical vein thrombosis. However, the epidemiological features of CVT in China mainland remained obscure. This study was aimed to establish a multicenter cohort recruiting patients with CVT across 31 provinces and municipalities in China mainland. Clinical features,natural history of the diseases and current therapeutic situations will be analyzed to reveal the epidemiological features of CVT. Blood samples and cerebrospinal fluid samples will be collected after recruitment to reveal the pathological mechanisms of CVT and identify the biomarkers for CVT. Patients will be followed-up at 1, 3, 6, 12 months from baseline to evaluate the clinical prognosis and therapeutic outcomes.

Conditions

Timeline

Start date
2019-06-01
Primary completion
2028-05-31
Completion
2029-05-31
First posted
2019-04-18
Last updated
2019-04-18

Source: ClinicalTrials.gov record NCT03919305. Inclusion in this directory is not an endorsement.